2025年7月14日 周一
首页 > 按月查看>2018年第6月 >621-625
PDF 导出
冠心病患者血清磷脂转运蛋白活性与冠状动脉病变严重程度的相关分析
作者:
作者单位:

(1.无锡市锡山人民医院心血管内科,江苏省无锡市214011;2.东南大学附属中大医院心血管内科,江苏省南京市210000)

作者简介:

陈益飞,副主任医师,主要从事冠心病临床研究和介入治疗,E-mail为cyfwuxi@sohu.com。

基金项目:

无锡市卫生局面上科研项目(ME201502)


Correlation between serum phospholipid transfer protein activity levels and severity of coronary artery lesions in patients with coronary heart disease
Author:
Affiliation:

1.Department of Cardiology, Xishan People’s Hospital of Wuxi, Wuxi, Jiangsu 214011, China;2.Department of Cardiology, Zhongda Hospital of Southeast University, Nanjing, Jiangsu 210000, China)

  • 摘要
    • | |
  • 访问统计
    • |
  • 参考文献
    • |
  • 相似文献
    • | |
    摘要:

    目的 分析冠心病患者血清磷脂转运蛋白活性水平与冠状动脉病变严重程度的相关性。方法 2015年6月至2016年6月期间,无锡市锡山人民医院心血管科顺序入选胸痛患者202例,行冠状动脉造影术后分为冠心病组(n=121)和非冠心病组(n=81), 计算Gensini评分,测定血清磷脂转运蛋白活性水平并行常规实验室检查。结果 冠心病组磷脂转运蛋白活性水平和Gensini评分显著高于非冠心病组[90.3(67～118) mg/dL比77.4(54.6～103.3) mg/dL,P<0.05；29(8～48)比2(0～6),P<0.001]。70～79岁与69岁及以下、男性与女性、糖尿病与非糖尿病患者相比,磷脂转运蛋白活性水平和Gensini评分明显升高(P＜0.05)。多重线性回归分析提示冠心病组患者磷脂转运蛋白与Gensini评分相关(Beta=0.356,P<0.001)。ROC曲线分析显示磷脂转运蛋白曲线下面积为0.749(P<0.001)。结论 冠心病组磷脂转运蛋白活性水平与冠状动脉病变严重程度相关,磷脂转运蛋白活性水平可预测冠状动脉病变严重程度。

    Abstract:

    Aim To investigate the relationship between serum phospholipid transfer protein (PLTP) activity levels and severity of coronary artery lesions in patients with coronary heart disease (CHD). Methods 202 patients with chest pain were recruited in the Xishan People’s Hospital of Wuxi from June 2015 to June 2016, and these patients were divided into two groups based on coronary angiography (CHD group and non-CHD group). PLTP activity was measured with an assay kit, and the severity of coronary artery disease assessed by Gensini score was analyzed. Results PLTP activity levels and Gensini score in CHD group were significantly higher than that in non-CHD group (90.3(67～118)mg/dL vs 77.4 (54.6～103.3)mg/dL, P<0.05; 29(8～48) vs 2(0～6), P<0.001). PLTP activity levels and Gensini score were higher in patients aged 70～79 years old,male and diabetes than patients aged 60～69 years old, female and non-diabetes. Multiple linear regression analysis showed that PLTP activity levels were predictor for Gensini score after adjusting for the other risk factors (Beta=0.356, P<0.001). ROC curve was for PLTP activity levels to detect CHD patients with upper Gensini score quartile, and the area under the curve was 0.749(P<0.001). Conclusion Serum PLTP activity levels were predictive for the severity of coronary artery lesions in patients with CHD.

    参考文献
    [1] Gensini G G.A more meaningful scoring system for determining the severity of coronary heart disease.Am J Cardiol, 3,1(3):606.
    [2] Fruchart J C, Davignon J, Hermans M P, et al.Residual macrovascular risk in 2013:what have we learned? .Cardiovasc Diabetol, 4,3:26.
    [3] Gross J J, Kessler E C, Albrecht C, et al.Response of the cholesterol metabolism to a negative energy balance in dairy cows depends on the lactational stage.PLoS One, 5,0(6):e0121956.
    [4] Vikstedt R, Ye D, Metso J, et al.Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.Arterioscler Thromb Vasc Biol, 7,7(3):578-586.
    [5] Dullaart R P, Garcia E, Jeyarajah E, et al.Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.Lipids Health Dis, 6,5(1):143.
    [6] Chen X, Sun A, Zou Y, et al.High PLTP activity is associated with depressed left ventricular systolic function.Atherosclerosis, 3,8(2):438-442.
    [7] Cavusoglu E, Marmur J D, Chhabra S, et al.Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography.Atherosclerosis, 9,7(1):261-265.
    [8] Van Linthout S, Hamdani N, Miteva K, et al.Placenta-derived adherent stromal cells improve diabetes mellitus-associated left ventricular diastolic performance.Stem Cells Transl Med, 7,6(12):2 135-145.
    [9] Pohlel K, Grow P, Helmy T, et al.Treating dyslipidemia in the elderly.Curr Opin Lipidol, 6,7(1):54-57.
    [10] Taravatmanesh S, Khalili D, Khodakarim S, et al.Determining the factors associated with cardiovascular disease recurrence:tehran lipid and glucose study.J Tehran Heart Cent, 7,2(3):107-113.
    [11] Yilmaz M, Altin C, Ozyildiz A, et al.Are oxidative stress markers helpful for diagnosing the disease and determining its complexity or extent in patients with stable coronary artery disease?.Turk Kardiyol Dern Ars, 7,5(7):599-605.
    [12] Frstermann U.Nitric oxide and oxidative stress in vascular disease.Pflugers Arch, 0,9(6):923-939.
    [13] Niccoli G, Giubilato S, Di Vito L, et al.Severity of coronary atherosclerosis in patients with a first acute coronary event:a diabetes paradox.Eur Heart J, 3,4(10):729-741.
    [14] Zornitzki T, Ayzenberg O, Gandelman G, et al.Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.QJM, 7,0(9):575-581.
    [15] Desrumaux C, Deckert V, Lemaire-Ewing S, et al.Plasma phospholipid transfer protein deficiency in mice is associated with a reduced thrombotic response to acute intravascular oxidative stress.Arterioscler Thromb Vasc Biol, 0,0(12):2 452-457.
    [16] de Vries R, Kappelle P J, Dallinga-Thie GM, et al.Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects.Atherosclerosis, 1,7(1):253-259.
    [17] Desrumaux C, Lemaire-Ewing S, Ogier N, et al.Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization.Cell Mol Immunol, 6,3(6):795-804.
    [18] Zhang K, Liu X, Yu Y, et al.Phospholipid transfer protein destabilizes mouse atherosclerotic plaque.Arterioscler Thromb Vasc Biol, 4,4(12):2 537-544.
    [19] Yang X, Yu Y, Wang D, et al.Overexpressed PLTP in macrophage may promote cholesterol accumulation by prolonged endoplasmic reticulum stress.Med Hypotheses, 7,8:45-48.
    引证文献
引用本文

陈益飞,季竹君,李旭东,黄勇先,钱中良,邱洁瑜,朱晓明,刘乃丰.冠心病患者血清磷脂转运蛋白活性与冠状动脉病变严重程度的相关分析[J].中国动脉硬化杂志,2018,26(6):621~625.

复制
分享
文章指标
  • 点击次数:963
  • 下载次数: 803
历史
  • 收稿日期:2017-11-15
  • 最后修改日期:2018-04-17
  • 在线发布日期: 2018-07-10

您是本站第 4939401 访问者

邮编：421001 传真：0734-8160523

电话：0734-8160765 E-mail：dmzzbjb@163.net

中国动脉硬化杂志 ® 2025 网站版权所有